Vicken Karageozian, MD, is president and CEO of Allegro Ophthalmics. Dr. Karageozian has nearly 25 years’ experience building and leading companies in the ophthalmic pharmaceutical space. He is the co-founder of Allegro, ISTA Pharmaceuticals, and Vitreoretinal Technologies, and has been instrumental in the raising of over $240M in venture, corporate, and institutional capital.
The inventor or co-inventor of numerous ophthalmic pharmaceuticals with 82 patents issued or pending, Dr. Karageozian’s co-inventions include some of the first enzymatic, osmotic, and integrin-based treatments for the eye and some of the earliest work in intravitreal injections.
Dr. Karageozian graduated from the University of California, San Diego, received his medical degree from Tufts University School of Medicine, and completed his ophthalmology residency at the University of California, Irvine.